Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:3132-3136
doi: 10.1161/hc5001.100832
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Osanai, T.
Right arrow Articles by Okumura, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Osanai, T.
Right arrow Articles by Okumura, K.
Related Collections
Right arrow Other Vascular biology
Right arrow Cell signalling/signal transduction

(Circulation. 2001;104:3132.)
© 2001 American Heart Association, Inc.


Basic Science Reports

Mitochondrial Coupling Factor 6 Is Present on the Surface of Human Vascular Endothelial Cells and Is Released by Shear Stress

Tomohiro Osanai, MD; Satoko Okada, MD; Kenichi Sirato, MD; Takao Nakano, MD; Masayuki Saitoh, MD; Koji Magota, PhD; Ken Okumura, MD

From the Second Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, and Pharmaceutical Research Laboratories, Suntory Biomedical Research Ltd, Osaka (K.M.), Japan.

Correspondence to Tomohiro Osanai, MD, The Second Department of Internal Medicine, Hirosaki University School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562 Japan. E-mail osanait{at}cc.hirosaki-u.ac.jp

Background We showed that mitochondrial coupling factor 6 (CF6), an endogenous inhibitor of prostacyclin synthesis, is present in the systemic circulation as a pressor substance in rats. We investigated the possibility of vascular endothelial cells as a source of circulating CF6.

Methods and Results We used 2 cultured endothelial cell lines, human umbilical vein endothelial cells (HUVECs) and ECV 304 cells (transformed HUVECs), for this study. Immunofluorescence microscopy of both ECV 304 and HUVECs confirmed the surface-associated immunoreactivity of anti-CF6 antibody on the plasma membrane. The concentration of CF6 in the medium increased gradually with time in both ECV 304 and HUVECs in static conditions. Exposure of ECV 304 and HUVECs to a fluid shear stress enhanced the release of CF6: In ECV 304, the concentration of CF6 in the medium (ng · well-1 · 6 hours-1) was 2.1±0.8 at baseline, 4.3±0.8 after shear at 15 dynes/cm2, and 57.7±8.4 after shear at 25 dynes/cm2. CF6 contents in the cell homogenate and mitochondria were both significantly increased after exposure of ECV 304 to 6-hour shear at 15 dynes/cm2, whereas they were unchanged after shear stress at 25 dynes/cm2. The ratio of CF6 to GAPDH mRNA was enhanced significantly, by 1.8±0.2-fold, after 6-hour shear stress at 25 dynes/cm2. Flow cytometry analysis revealed that the surface-associated CF6 was significantly increased in a 3-hour static condition after the previous exposure of the cells to shear stress for 3 hours.

Conclusions Vascular endothelial cells are a source of CF6, and shear stress regulates the release of the surface-associated CF6.


Key Words: endothelium • blood flow • hormones • prostaglandins • vasoconstriction




This article has been cited by other articles:


Home page
HypertensionHome page
T. Osanai, K. Magota, M. Tanaka, M. Shimada, R. Murakami, S. Sasaki, H. Tomita, N. Maeda, and K. Okumura
Intracellular Signaling for Vasoconstrictor Coupling Factor 6: Novel Function of {beta}-Subunit of ATP Synthase as Receptor
Hypertension, November 1, 2005; 46(5): 1140 - 1146.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. W. Watts
Vasoconstriction Caused by the ATP Synthase Subunit-Coupling Factor 6: A New Function for a Historical Enzyme
Hypertension, November 1, 2005; 46(5): 1100 - 1102.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Tomita, T. Osanai, T. Toki, S. Sasaki, N. Maeda, R. Murakami, K. Magota, M. Yasujima, and K. Okumura
Troglitazone and 15-deoxy-{Delta}12,14-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells
Cardiovasc Res, July 1, 2005; 67(1): 134 - 141.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Sasaki, T. Osanai, H. Tomita, T. Matsunaga, K. Magota, and K. Okumura
Tumor necrosis factor {alpha} as an endogenous stimulator for circulating coupling factor 6
Cardiovasc Res, June 1, 2004; 62(3): 578 - 586.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Ameshima, H. Golpon, C. D. Cool, D. Chan, R. W. Vandivier, S. J. Gardai, M. Wick, R. A. Nemenoff, M. W. Geraci, and N. F. Voelkel
Peroxisome Proliferator-Activated Receptor Gamma (PPAR{gamma}) Expression Is Decreased in Pulmonary Hypertension and Affects Endothelial Cell Growth
Circ. Res., May 30, 2003; 92(10): 1162 - 1169.
[Abstract] [Full Text] [PDF]